Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 4 | ||
Ligand | BDBM639199 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | IRAK4 ADP-Glo Assay | ||
IC50 | 5.60±n/a nM | ||
Citation | Chen, Y; Masuda, E; Lamagna, C BICYCLIC INHIBITORS OF IRAK US Patent US20230391748 Publication Date 12/7/2023 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 4 | |||
Name: | Interleukin-1 receptor-associated kinase 4 | ||
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 | ||
Type: | Protein | ||
Mol. Mass.: | 51519.08 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9NWZ3 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM639199 | |||
n/a | |||
Name | BDBM639199 | ||
Synonyms: | 4-((cis-4-ethoxycyclohexyl)ethynyl)-7-isopropoxy-1-(((S)-5-oxopyrrolidin-2-yl)methoxy)isoquinoline-6-carboxamide | US20230391748, Compound I-21 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H35N3O5 | ||
Mol. Mass. | 493.5946 | ||
SMILES | CCO[C@H]1CC[C@H](CC1)C#Cc1cnc(OC[C@@H]2CCC(=O)N2)c2cc(OC(C)C)c(cc12)C(N)=O |r,wU:17.17,6.9,3.2,(-11.09,-.71,;-9.55,-.71,;-8.78,-2.04,;-7.24,-2.04,;-6.47,-.71,;-4.93,-.71,;-4.16,-2.04,;-4.93,-3.38,;-6.47,-3.38,;-2.62,-2.04,;-1.08,-2.04,;.46,-2.04,;1.23,-3.38,;2.77,-3.38,;3.54,-2.04,;5.08,-2.04,;5.85,-3.38,;7.39,-3.38,;8.29,-4.62,;9.76,-4.15,;9.76,-2.61,;11.09,-1.84,;8.29,-2.13,;2.77,-.71,;3.54,.62,;2.77,1.96,;3.54,3.29,;5.08,3.29,;5.85,4.62,;5.85,1.96,;1.23,1.96,;.46,.62,;1.23,-.71,;.46,3.29,;1.23,4.62,;-1.08,3.29,)| | ||
Structure |